Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pathogenesis of psoriasis and current challenges.
Gupta AK, Langley R, Poulin Y, Lui H, Searles G, Carey W, Toole J, Inniss K. Gupta AK, et al. J Cutan Med Surg. 2004 Aug;8 Suppl:3-7. doi: 10.1007/s10227-004-2002-7. J Cutan Med Surg. 2004. PMID: 15655583 No abstract available.
Incorporating biologics into the treatment of psoriasis.
Lui H, Langley R, Poulin Y, Gupta AK, Carey W, Guenther L, Searles G, Toole J, Lynde C, Gulliver W, Barber K. Lui H, et al. J Cutan Med Surg. 2004 Aug;8 Suppl:8-13. doi: 10.1007/s10227-004-2003-6. J Cutan Med Surg. 2004. PMID: 15655584 Review. No abstract available.
The use of alefacept in the treatment of psoriasis.
Langley R, Gupta AK, Poulin Y, Guenther L, Barber K, Gulliver W, Lynde C. Langley R, et al. J Cutan Med Surg. 2004 Aug;8 Suppl:14-8. doi: 10.1007/s10227-004-2004-5. J Cutan Med Surg. 2004. PMID: 15655585 Review. No abstract available.
Use of pimecrolimus cream 1% (Elidel) in the treatment of atopic dermatitis in infants and children: the effects of ethnic origin and baseline disease severity on treatment outcome.
Eichenfield LF, Lucky AW, Langley RG, Lynde C, Kaufmann R, Todd G, Lindsley L, Barbier N, Felser JM. Eichenfield LF, et al. Among authors: langley rg. Int J Dermatol. 2005 Jan;44(1):70-5. doi: 10.1111/j.1365-4632.2004.02234.x. Int J Dermatol. 2005. PMID: 15663667 Clinical Trial.
Efalizumab, a reversible T-cell modulator for psoriasis.
Shear NH, Langley RG, Ho V. Shear NH, et al. Among authors: langley rg. J Cutan Med Surg. 2006;9 Suppl 1:4-9. doi: 10.1007/s10227-006-0101-3. J Cutan Med Surg. 2006. PMID: 16633862 Review.
211 results